GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma

$615,811
Sandra P D'angelo · Sloan-Kettering Inst Can Research · R01 · FY2023 · FD

MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors

$615,777
Jeremy J Heit · Stanford University · R01 · FY2021 · CA

The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma

$615,760
Evan Newell · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Multi-receptor Targeting of Glioblastoma

$615,701
Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2023 · CA

Decoding tumor metabolic and immunologic interactions driving different biological subtypes in patients with bladder cancer.

$615,400
Nagireddy Putluri · Baylor College Of Medicine · R01 · FY2025 · CA

Novel approach to modulate the TME on-demand with therapeutic peptides and proteins.

$615,399
Kit S Lam · University Of California At Davis · R01 · FY2025 · CA

TRPV1 nociceptors in oral carcinogenesis and pain

$615,159
Donna G Albertson · New York University · R01 · FY2025 · CA

Host and parasite determinants of Leishmania Viannia persistence in naturally infected human populations

$615,131
Najib M. El-Sayed · Univ Of Maryland, College Park · R01 · FY2024 · AI

Regulatory T cells in cancer therapy

$614,963
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

CTL-killing capacity and cancer stiffness in cancer immunity and therapy

$614,951
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Engineering personalized micro-tumor ecosystems

$614,945
Shiladitya Sengupta · Brigham And Women'S Hospital · U01 · FY2021 · CA

Transcriptional Reprogramming in Melanoma Plasticity

$614,911
Chengyu Liang · Wistar Institute · R01 · FY2024 · CA

Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance

$614,870
Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas

$614,852
Duane A. Mitchell · University Of Florida · R01 · FY2019 · CA

Naive T cells in Cancer Immune Evasion and Immunotherapy

$614,741
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Extracellular pH mapping as therapeutic readout of drug delivery in glioblastoma

$614,739
Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2019 · EB

Extracellular pH mapping as therapeutic readout of drug delivery in glioblastoma

$614,739
Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2018 · EB

Extracellular pH mapping as therapeutic readout of drug delivery in glioblastoma

$614,738
Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2020 · EB

BMP2 Regulation of Periosteal Function

$614,692
Vicki Rosen · Harvard Medical School · R01 · FY2020 · AR

Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01

$614,692
Chin-Tu Chen · University Of Chicago · R01 · FY2021 · CA

Mechanical regulation of the microenvironmental niche in skin tumorigenesis

$614,647
Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

A Human Intraepithelial Tumor Microenvironment Assay

$614,540
Barbara Lynn Allen-Hoffmann · Stratatech Corporation · R42 · FY2010 · CA

Training in Areas Fundamental to Cancer Research

$614,536
Ashani T Weeraratna · Johns Hopkins University · T32 · FY2023 · CA

Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer

$614,511
Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2020 · CA

Dissecting the role of hypoxia in T cell differentiation in cancer

$614,462
Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA